

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.59565955 |
| 2 | surfactant homeostasis (GO:0043129) | 4.01958397 |
| 3 | cell adhesion mediated by integrin (GO:0033627) | 3.85999908 |
| 4 | response to peptidoglycan (GO:0032494) | 3.78366029 |
| 5 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.71901726 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.59999375 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 3.59023108 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.54782143 |
| 9 | B cell receptor signaling pathway (GO:0050853) | 3.50575439 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47447736 |
| 11 | wound healing, spreading of epidermal cells (GO:0035313) | 3.42386720 |
| 12 | hepatocyte apoptotic process (GO:0097284) | 3.39915503 |
| 13 | definitive hemopoiesis (GO:0060216) | 3.35639517 |
| 14 | detection of molecule of bacterial origin (GO:0032490) | 3.33333458 |
| 15 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32105912 |
| 16 | response to host (GO:0075136) | 3.32105912 |
| 17 | response to host defenses (GO:0052200) | 3.32105912 |
| 18 | response to host immune response (GO:0052572) | 3.31889130 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.31889130 |
| 20 | iron ion import (GO:0097286) | 3.29201288 |
| 21 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.28420439 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.28292824 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.28189551 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.28189551 |
| 25 | basement membrane organization (GO:0071711) | 3.27998703 |
| 26 | cellular extravasation (GO:0045123) | 3.26437360 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.23861091 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.14059979 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.14059979 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.14059979 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.14059979 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.14059979 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.14059979 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12899734 |
| 35 | regulation of macrophage cytokine production (GO:0010935) | 3.08861872 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06963345 |
| 37 | microglial cell activation (GO:0001774) | 3.06171273 |
| 38 | establishment of endothelial barrier (GO:0061028) | 3.04371736 |
| 39 | regulation of leukocyte degranulation (GO:0043300) | 3.02499450 |
| 40 | virion attachment to host cell (GO:0019062) | 3.02478598 |
| 41 | adhesion of symbiont to host cell (GO:0044650) | 3.02478598 |
| 42 | mesodermal cell differentiation (GO:0048333) | 3.01749889 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.00220812 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 2.98170964 |
| 45 | macrophage activation (GO:0042116) | 2.95104004 |
| 46 | histone H3-K36 demethylation (GO:0070544) | 2.94548556 |
| 47 | germ cell migration (GO:0008354) | 2.93995482 |
| 48 | apoptotic cell clearance (GO:0043277) | 2.92252211 |
| 49 | response to laminar fluid shear stress (GO:0034616) | 2.90777642 |
| 50 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89097177 |
| 51 | wound healing, spreading of cells (GO:0044319) | 2.88740006 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 2.86153477 |
| 53 | adhesion of symbiont to host (GO:0044406) | 2.85806244 |
| 54 | hemidesmosome assembly (GO:0031581) | 2.83276357 |
| 55 | morphogenesis of an endothelium (GO:0003159) | 2.79958132 |
| 56 | endothelial tube morphogenesis (GO:0061154) | 2.79958132 |
| 57 | detection of biotic stimulus (GO:0009595) | 2.79707647 |
| 58 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.76635010 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.76635010 |
| 60 | low-density lipoprotein particle clearance (GO:0034383) | 2.75683487 |
| 61 | myeloid cell activation involved in immune response (GO:0002275) | 2.73418979 |
| 62 | chemical homeostasis within a tissue (GO:0048875) | 2.72815865 |
| 63 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.69863446 |
| 64 | protein localization to endosome (GO:0036010) | 2.69615511 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 2.67449423 |
| 66 | endothelial cell morphogenesis (GO:0001886) | 2.66777939 |
| 67 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.65559633 |
| 68 | positive thymic T cell selection (GO:0045059) | 2.65162349 |
| 69 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.65136658 |
| 70 | macrophage activation involved in immune response (GO:0002281) | 2.64371557 |
| 71 | viral entry into host cell (GO:0046718) | 2.63164099 |
| 72 | regulation of mast cell degranulation (GO:0043304) | 2.62400082 |
| 73 | response to type I interferon (GO:0034340) | 2.61990089 |
| 74 | cellular response to type I interferon (GO:0071357) | 2.61092403 |
| 75 | type I interferon signaling pathway (GO:0060337) | 2.61092403 |
| 76 | regulation of regulated secretory pathway (GO:1903305) | 2.60938493 |
| 77 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.60030063 |
| 78 | actin nucleation (GO:0045010) | 2.59707454 |
| 79 | positive regulation of interferon-alpha production (GO:0032727) | 2.58742878 |
| 80 | embryonic process involved in female pregnancy (GO:0060136) | 2.58547055 |
| 81 | renal filtration (GO:0097205) | 2.58123181 |
| 82 | regulation of B cell differentiation (GO:0045577) | 2.57991766 |
| 83 | hypotonic response (GO:0006971) | 2.57922631 |
| 84 | regulation of tolerance induction (GO:0002643) | 2.56654224 |
| 85 | megakaryocyte development (GO:0035855) | 2.54788593 |
| 86 | response to muramyl dipeptide (GO:0032495) | 2.54630731 |
| 87 | pinocytosis (GO:0006907) | 2.53842629 |
| 88 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.52223173 |
| 89 | cellular response to growth hormone stimulus (GO:0071378) | 2.51025315 |
| 90 | endodermal cell differentiation (GO:0035987) | 2.50975972 |
| 91 | regulation of endothelial cell differentiation (GO:0045601) | 2.50843792 |
| 92 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.50650192 |
| 93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.50008177 |
| 94 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.48699032 |
| 95 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.47462665 |
| 96 | respiratory burst (GO:0045730) | 2.46912552 |
| 97 | peptide catabolic process (GO:0043171) | 2.46750394 |
| 98 | I-kappaB phosphorylation (GO:0007252) | 2.46705863 |
| 99 | skin morphogenesis (GO:0043589) | 2.45802214 |
| 100 | positive regulation of regulated secretory pathway (GO:1903307) | 2.45760909 |
| 101 | endothelium development (GO:0003158) | 2.45730855 |
| 102 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.45202313 |
| 103 | detection of other organism (GO:0098543) | 2.44629100 |
| 104 | regulation of interferon-alpha production (GO:0032647) | 2.44418316 |
| 105 | lipid translocation (GO:0034204) | 2.44306578 |
| 106 | phospholipid translocation (GO:0045332) | 2.44306578 |
| 107 | integrin-mediated signaling pathway (GO:0007229) | 2.43037866 |
| 108 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.42912948 |
| 109 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42461612 |
| 110 | dosage compensation (GO:0007549) | 2.40957909 |
| 111 | cellular response to interferon-alpha (GO:0035457) | 2.40048844 |
| 112 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37386591 |
| 113 | hyaluronan catabolic process (GO:0030214) | 2.36857102 |
| 114 | positive regulation of tolerance induction (GO:0002645) | 2.36677250 |
| 115 | positive regulation of macrophage cytokine production (GO:0060907) | 2.36159819 |
| 116 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.35831582 |
| 117 | angiotensin maturation (GO:0002003) | 2.34695406 |
| 118 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.34521014 |
| 119 | B cell mediated immunity (GO:0019724) | 2.34519707 |
| 120 | positive regulation of antigen processing and presentation (GO:0002579) | 2.32966313 |
| 121 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.30519759 |
| 122 | membrane raft organization (GO:0031579) | 2.29101814 |
| 123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.28637899 |
| 124 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.28561433 |
| 125 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.28541426 |
| 126 | detection of bacterium (GO:0016045) | 2.28368204 |
| 127 | leukocyte cell-cell adhesion (GO:0007159) | 2.28301750 |
| 128 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.27971936 |
| 129 | growth hormone receptor signaling pathway (GO:0060396) | 2.27948722 |
| 130 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.27620061 |
| 131 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.27279097 |
| 132 | angiogenesis involved in wound healing (GO:0060055) | 2.27118755 |
| 133 | positive regulation of osteoblast proliferation (GO:0033690) | 2.26534587 |
| 134 | positive regulation of p38MAPK cascade (GO:1900745) | 2.25660482 |
| 135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.23856607 |
| 136 | immunoglobulin mediated immune response (GO:0016064) | 2.22186399 |
| 137 | myeloid cell homeostasis (GO:0002262) | 2.20999755 |
| 138 | glomerular filtration (GO:0003094) | 2.19124659 |
| 139 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.19111971 |
| 140 | response to interferon-alpha (GO:0035455) | 2.16735019 |
| 141 | cortical actin cytoskeleton organization (GO:0030866) | 2.15399345 |
| 142 | regulation of podosome assembly (GO:0071801) | 2.15103604 |
| 143 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.14987603 |
| 144 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.14868297 |
| 145 | glomerular visceral epithelial cell development (GO:0072015) | 2.13701111 |
| 146 | nuclear pore complex assembly (GO:0051292) | 2.13533946 |
| 147 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.13345430 |
| 148 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.13246721 |
| 149 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.13129642 |
| 150 | negative regulation of interleukin-8 production (GO:0032717) | 2.13054969 |
| 151 | neutrophil activation (GO:0042119) | 2.12485240 |
| 152 | response to fluid shear stress (GO:0034405) | 2.12253678 |
| 153 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.11756226 |
| 154 | positive regulation of lamellipodium assembly (GO:0010592) | 2.10493172 |
| 155 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.10349755 |
| 156 | entry into host cell (GO:0030260) | 2.08210916 |
| 157 | movement in environment of other organism involved in symbiotic interaction (GO:0052192) | 2.08210916 |
| 158 | entry into cell of other organism involved in symbiotic interaction (GO:0051806) | 2.08210916 |
| 159 | entry into host (GO:0044409) | 2.08210916 |
| 160 | entry into other organism involved in symbiotic interaction (GO:0051828) | 2.08210916 |
| 161 | movement in host environment (GO:0052126) | 2.08210916 |
| 162 | endocardial cushion development (GO:0003197) | 2.07820251 |
| 163 | actin filament depolymerization (GO:0030042) | 2.07437337 |
| 164 | positive regulation of leukocyte degranulation (GO:0043302) | 2.07371988 |
| 165 | interferon-gamma secretion (GO:0072643) | 2.07125497 |
| 166 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.06811404 |
| 167 | regulation of antigen processing and presentation (GO:0002577) | 2.06526181 |
| 168 | leukocyte aggregation (GO:0070486) | 2.06014798 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.10832321 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.58368915 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.43529668 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05623442 |
| 5 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.97076708 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.88352263 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.65386545 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.63618863 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.63084608 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58722290 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.51481737 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.50112931 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.43436444 |
| 14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36794958 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.34198328 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33301781 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32026680 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.28164858 |
| 19 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.19227123 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.18326185 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14268611 |
| 22 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.10844998 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08931108 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.06722819 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00499416 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91505644 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.88387392 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.87706501 |
| 29 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87035606 |
| 30 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.78813836 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78249094 |
| 32 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.77200818 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.76714601 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76533029 |
| 35 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.75167764 |
| 36 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.75167764 |
| 37 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74015059 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.73414248 |
| 39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.72306466 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.71162953 |
| 41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69597469 |
| 42 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.68916492 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.67862284 |
| 44 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.62667722 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62127714 |
| 46 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58739805 |
| 47 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.58417598 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58041057 |
| 49 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.57466117 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.55992020 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52437067 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50654053 |
| 53 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.50425344 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49610144 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48080723 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.47552177 |
| 57 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.44450491 |
| 58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42900726 |
| 59 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.41672374 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41448170 |
| 61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41428307 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40601082 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.40098788 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38678162 |
| 65 | GATA2_19941826_ChIP-Seq_K562_Human | 1.38493888 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37819172 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.36637367 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.36341859 |
| 69 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33695967 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32512026 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32017717 |
| 72 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31886320 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.30959054 |
| 74 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30116694 |
| 75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30112744 |
| 76 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29908437 |
| 77 | MYB_26560356_Chip-Seq_TH2_Human | 1.28476140 |
| 78 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27364444 |
| 79 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.26852226 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26020865 |
| 81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24639874 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22612868 |
| 83 | MAF_26560356_Chip-Seq_TH1_Human | 1.22090806 |
| 84 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21614605 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20961655 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19278162 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18692614 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18380817 |
| 89 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.18205713 |
| 90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17502712 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 1.16269647 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16228320 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15748860 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15274824 |
| 95 | ATF3_27146783_Chip-Seq_COLON_Human | 1.15252784 |
| 96 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.15117236 |
| 97 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15057179 |
| 98 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13836030 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13034896 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12907507 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11707052 |
| 102 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.10080535 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.09609891 |
| 104 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09183294 |
| 105 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08737330 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08481495 |
| 107 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.07674327 |
| 108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07175727 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07158023 |
| 110 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06395119 |
| 111 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06395119 |
| 112 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06395119 |
| 113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06381600 |
| 114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.04718044 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.03999270 |
| 116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03785307 |
| 117 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00958489 |
| 118 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99719802 |
| 119 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.99487787 |
| 120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99275038 |
| 121 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96148500 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95822616 |
| 123 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95444266 |
| 124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95238398 |
| 125 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95031120 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94816849 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94526568 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92116103 |
| 129 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90895213 |
| 130 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89443566 |
| 131 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88461354 |
| 132 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.88239942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 2.91427314 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 2.86532451 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.80128851 |
| 4 | MP0010352_gastrointestinal_tract_polyps | 2.60463134 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.56027742 |
| 6 | MP0001958_emphysema | 2.49510822 |
| 7 | MP0006054_spinal_hemorrhage | 2.41331048 |
| 8 | MP0002009_preneoplasia | 2.33158125 |
| 9 | MP0003566_abnormal_cell_adhesion | 2.31678837 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.24776795 |
| 11 | MP0004272_abnormal_basement_membrane | 2.18738575 |
| 12 | MP0009278_abnormal_bone_marrow | 2.15970517 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.03019040 |
| 14 | MP0003303_peritoneal_inflammation | 2.00955479 |
| 15 | MP0003724_increased_susceptibility_to | 1.99372056 |
| 16 | MP0004264_abnormal_extraembryonic_tissu | 1.93259688 |
| 17 | MP0008260_abnormal_autophagy | 1.87812251 |
| 18 | * MP0003191_abnormal_cellular_cholesterol | 1.84712618 |
| 19 | MP0003763_abnormal_thymus_physiology | 1.80773638 |
| 20 | MP0005023_abnormal_wound_healing | 1.76913660 |
| 21 | MP0004782_abnormal_surfactant_physiolog | 1.76562676 |
| 22 | MP0005409_darkened_coat_color | 1.72616138 |
| 23 | MP0008004_abnormal_stomach_pH | 1.71791734 |
| 24 | MP0003436_decreased_susceptibility_to | 1.70880892 |
| 25 | MP0003091_abnormal_cell_migration | 1.66584428 |
| 26 | MP0010368_abnormal_lymphatic_system | 1.64246417 |
| 27 | MP0008057_abnormal_DNA_replication | 1.62649990 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.60430170 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.54807330 |
| 30 | MP0004947_skin_inflammation | 1.51641972 |
| 31 | MP0003448_altered_tumor_morphology | 1.49854869 |
| 32 | MP0009785_altered_susceptibility_to | 1.48426656 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.45567618 |
| 34 | MP0002419_abnormal_innate_immunity | 1.44711046 |
| 35 | MP0009840_abnormal_foam_cell | 1.43919696 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.43894288 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.43894288 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.43852704 |
| 39 | MP0005083_abnormal_biliary_tract | 1.43459680 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.43284656 |
| 41 | MP0003866_abnormal_defecation | 1.42561018 |
| 42 | MP0010307_abnormal_tumor_latency | 1.41591579 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.40640255 |
| 44 | MP0004883_abnormal_blood_vessel | 1.40619697 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.39715545 |
| 46 | MP0001873_stomach_inflammation | 1.38218445 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.34838788 |
| 48 | MP0001835_abnormal_antigen_presentation | 1.32159794 |
| 49 | MP0002398_abnormal_bone_marrow | 1.30630597 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.30126986 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.29794339 |
| 52 | MP0005025_abnormal_response_to | 1.28407195 |
| 53 | MP0005275_abnormal_skin_tensile | 1.28157073 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.26988195 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.25609196 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.23046580 |
| 57 | MP0005501_abnormal_skin_physiology | 1.22694075 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.19557755 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.17972116 |
| 60 | MP0000716_abnormal_immune_system | 1.15707259 |
| 61 | MP0005387_immune_system_phenotype | 1.12347585 |
| 62 | MP0001790_abnormal_immune_system | 1.12347585 |
| 63 | MP0005408_hypopigmentation | 1.10313036 |
| 64 | MP0005310_abnormal_salivary_gland | 1.09933747 |
| 65 | MP0004808_abnormal_hematopoietic_stem | 1.09051699 |
| 66 | MP0000490_abnormal_crypts_of | 1.08705349 |
| 67 | MP0000343_altered_response_to | 1.08456964 |
| 68 | MP0000858_altered_metastatic_potential | 1.07890005 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.05689677 |
| 70 | MP0005257_abnormal_intraocular_pressure | 1.03099564 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 1.02572747 |
| 72 | MP0003045_fibrosis | 1.02340819 |
| 73 | MP0005164_abnormal_response_to | 1.02089071 |
| 74 | MP0000015_abnormal_ear_pigmentation | 1.01256135 |
| 75 | MP0006082_CNS_inflammation | 1.00095714 |
| 76 | MP0002722_abnormal_immune_system | 0.99567922 |
| 77 | MP0002429_abnormal_blood_cell | 0.99327810 |
| 78 | MP0002295_abnormal_pulmonary_circulatio | 0.97853396 |
| 79 | MP0004381_abnormal_hair_follicle | 0.97716316 |
| 80 | MP0001819_abnormal_immune_cell | 0.97703089 |
| 81 | MP0005000_abnormal_immune_tolerance | 0.97273272 |
| 82 | MP0000689_abnormal_spleen_morphology | 0.96614643 |
| 83 | MP0003690_abnormal_glial_cell | 0.96581872 |
| 84 | MP0002420_abnormal_adaptive_immunity | 0.95756938 |
| 85 | MP0002396_abnormal_hematopoietic_system | 0.94855377 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.94412781 |
| 87 | MP0003828_pulmonary_edema | 0.94337548 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.94117109 |
| 89 | MP0002796_impaired_skin_barrier | 0.93110192 |
| 90 | MP0001851_eye_inflammation | 0.92789320 |
| 91 | MP0001845_abnormal_inflammatory_respons | 0.92425713 |
| 92 | MP0002405_respiratory_system_inflammati | 0.92217692 |
| 93 | MP0000685_abnormal_immune_system | 0.91965318 |
| 94 | MP0005621_abnormal_cell_physiology | 0.91787300 |
| 95 | MP0002723_abnormal_immune_serum | 0.91481404 |
| 96 | MP0001216_abnormal_epidermal_layer | 0.91332007 |
| 97 | MP0005671_abnormal_response_to | 0.90203491 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.89496633 |
| 99 | MP0000377_abnormal_hair_follicle | 0.89383883 |
| 100 | MP0003279_aneurysm | 0.88402385 |
| 101 | MP0000477_abnormal_intestine_morphology | 0.88159803 |
| 102 | MP0003941_abnormal_skin_development | 0.87647807 |
| 103 | MP0000733_abnormal_muscle_development | 0.87364976 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.85705880 |
| 105 | MP0000372_irregular_coat_pigmentation | 0.85507523 |
| 106 | MP0002006_tumorigenesis | 0.85102540 |
| 107 | MP0001800_abnormal_humoral_immune | 0.83978369 |
| 108 | MP0000371_diluted_coat_color | 0.83777752 |
| 109 | MP0002086_abnormal_extraembryonic_tissu | 0.83409083 |
| 110 | MP0000249_abnormal_blood_vessel | 0.83305973 |
| 111 | MP0005451_abnormal_body_composition | 0.82264330 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.81961656 |
| 113 | MP0000703_abnormal_thymus_morphology | 0.81887959 |
| 114 | MP0000427_abnormal_hair_cycle | 0.81175486 |
| 115 | MP0001915_intracranial_hemorrhage | 0.80720504 |
| 116 | MP0002060_abnormal_skin_morphology | 0.79858797 |
| 117 | MP0000383_abnormal_hair_follicle | 0.79697611 |
| 118 | MP0002132_abnormal_respiratory_system | 0.78159611 |
| 119 | MP0002168_other_aberrant_phenotype | 0.76991224 |
| 120 | MP0009333_abnormal_splenocyte_physiolog | 0.76976911 |
| 121 | MP0005165_increased_susceptibility_to | 0.76236280 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.75235423 |
| 123 | MP0009643_abnormal_urine_homeostasis | 0.74717271 |
| 124 | MP0003795_abnormal_bone_structure | 0.74304847 |
| 125 | MP0005388_respiratory_system_phenotype | 0.72860786 |
| 126 | MP0002133_abnormal_respiratory_system | 0.72860786 |
| 127 | MP0002925_abnormal_cardiovascular_devel | 0.72824665 |
| 128 | MP0000627_abnormal_mammary_gland | 0.72515739 |
| 129 | MP0000604_amyloidosis | 0.72159186 |
| 130 | MP0001614_abnormal_blood_vessel | 0.71915817 |
| 131 | MP0002098_abnormal_vibrissa_morphology | 0.71722061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Interstitial pulmonary disease (HP:0006530) | 5.08449452 |
| 2 | Hematochezia (HP:0002573) | 3.79640921 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.38658480 |
| 4 | Premature rupture of membranes (HP:0001788) | 3.35522748 |
| 5 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.29003204 |
| 6 | Osteolytic defects of the hand bones (HP:0009699) | 3.29003204 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.23698176 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.17138081 |
| 9 | Cerebral aneurysm (HP:0004944) | 2.92449859 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 2.86540009 |
| 11 | Cervical subluxation (HP:0003308) | 2.83225181 |
| 12 | Pustule (HP:0200039) | 2.82329949 |
| 13 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.82200785 |
| 14 | Recurrent cutaneous fungal infections (HP:0011370) | 2.82200785 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 2.74377236 |
| 16 | Recurrent bacterial skin infections (HP:0005406) | 2.72572515 |
| 17 | Spontaneous hematomas (HP:0007420) | 2.69624337 |
| 18 | Recurrent fungal infections (HP:0002841) | 2.67641402 |
| 19 | Recurrent viral infections (HP:0004429) | 2.66654369 |
| 20 | Esophageal varix (HP:0002040) | 2.65500426 |
| 21 | Atrophic scars (HP:0001075) | 2.63501022 |
| 22 | Ulnar bowing (HP:0003031) | 2.59906809 |
| 23 | Viral hepatitis (HP:0006562) | 2.53704132 |
| 24 | Orchitis (HP:0100796) | 2.51789237 |
| 25 | Aortic dissection (HP:0002647) | 2.47666141 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46750311 |
| 27 | Papillary thyroid carcinoma (HP:0002895) | 2.46640773 |
| 28 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.46014367 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 2.43267973 |
| 30 | Aortic aneurysm (HP:0004942) | 2.41874312 |
| 31 | Colitis (HP:0002583) | 2.41602765 |
| 32 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.37983081 |
| 33 | Prolonged bleeding time (HP:0003010) | 2.37821995 |
| 34 | Acute myeloid leukemia (HP:0004808) | 2.36299788 |
| 35 | T lymphocytopenia (HP:0005403) | 2.33593530 |
| 36 | Arterial thrombosis (HP:0004420) | 2.31941165 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.31741762 |
| 38 | Nonimmune hydrops fetalis (HP:0001790) | 2.31064645 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.29541225 |
| 40 | Subacute progressive viral hepatitis (HP:0006572) | 2.29008586 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.28652050 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28652050 |
| 43 | Ankyloglossia (HP:0010296) | 2.28171762 |
| 44 | Chest pain (HP:0100749) | 2.26101824 |
| 45 | Ileus (HP:0002595) | 2.26097658 |
| 46 | Urticaria (HP:0001025) | 2.25192979 |
| 47 | Gastrointestinal inflammation (HP:0004386) | 2.24829102 |
| 48 | Abnormality of nail color (HP:0100643) | 2.24681262 |
| 49 | Optic neuritis (HP:0100653) | 2.23414479 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.23414479 |
| 51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21719590 |
| 52 | Spondylolisthesis (HP:0003302) | 2.17965956 |
| 53 | Meningitis (HP:0001287) | 2.17870351 |
| 54 | Flat acetabular roof (HP:0003180) | 2.17616547 |
| 55 | Absent frontal sinuses (HP:0002688) | 2.17437943 |
| 56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17188447 |
| 57 | Thoracolumbar scoliosis (HP:0002944) | 2.17029654 |
| 58 | Rectal prolapse (HP:0002035) | 2.16973433 |
| 59 | Ankle contracture (HP:0006466) | 2.16863490 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.16277005 |
| 61 | Deep philtrum (HP:0002002) | 2.15854653 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.15584430 |
| 63 | Abnormality of T cell number (HP:0011839) | 2.14391055 |
| 64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.13217343 |
| 65 | Epistaxis (HP:0000421) | 2.11151380 |
| 66 | Peritonitis (HP:0002586) | 2.11053973 |
| 67 | Thick nail (HP:0001805) | 2.10029817 |
| 68 | Gastrointestinal infarctions (HP:0005244) | 2.08808145 |
| 69 | Shallow orbits (HP:0000586) | 2.08758527 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.08516134 |
| 71 | Protrusio acetabuli (HP:0003179) | 2.06433403 |
| 72 | Petechiae (HP:0000967) | 2.05770182 |
| 73 | Abnormality of oral frenula (HP:0000190) | 2.05664321 |
| 74 | Metaphyseal cupping (HP:0003021) | 2.05097981 |
| 75 | * Osteomyelitis (HP:0002754) | 2.04615891 |
| 76 | Curly hair (HP:0002212) | 2.04596136 |
| 77 | Increased mean platelet volume (HP:0011877) | 2.04277926 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03595749 |
| 79 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03595749 |
| 80 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03595749 |
| 81 | Cheilitis (HP:0100825) | 2.02194409 |
| 82 | Abnormal platelet volume (HP:0011876) | 2.01879386 |
| 83 | Coarse hair (HP:0002208) | 1.98752201 |
| 84 | Thin bony cortex (HP:0002753) | 1.98546517 |
| 85 | Autoimmune hemolytic anemia (HP:0001890) | 1.97658324 |
| 86 | Severe short stature (HP:0003510) | 1.95896408 |
| 87 | Hyperactive renin-angiotensin system (HP:0000841) | 1.95852694 |
| 88 | Recurrent bronchitis (HP:0002837) | 1.93785531 |
| 89 | Cupped ribs (HP:0000887) | 1.92433600 |
| 90 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.92296596 |
| 91 | Arterial tortuosity (HP:0005116) | 1.91966059 |
| 92 | Amyloidosis (HP:0011034) | 1.91645720 |
| 93 | Radial bowing (HP:0002986) | 1.91240163 |
| 94 | Conjunctival telangiectasia (HP:0000524) | 1.89900314 |
| 95 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89339371 |
| 96 | Periodontitis (HP:0000704) | 1.88823323 |
| 97 | Vasculitis (HP:0002633) | 1.88403383 |
| 98 | Gingivitis (HP:0000230) | 1.87736384 |
| 99 | Vascular tortuosity (HP:0004948) | 1.87578862 |
| 100 | Bowing of the arm (HP:0006488) | 1.86741953 |
| 101 | Bowed forearm bones (HP:0003956) | 1.86741953 |
| 102 | Chronic otitis media (HP:0000389) | 1.86696561 |
| 103 | Focal segmental glomerulosclerosis (HP:0000097) | 1.86531210 |
| 104 | Spinal cord lesions (HP:0100561) | 1.86479307 |
| 105 | Syringomyelia (HP:0003396) | 1.86479307 |
| 106 | Abnormality of chloride homeostasis (HP:0011422) | 1.84356049 |
| 107 | Abnormality of the lumbar spine (HP:0100712) | 1.83976329 |
| 108 | * Skin ulcer (HP:0200042) | 1.80798524 |
| 109 | Agammaglobulinemia (HP:0004432) | 1.80580837 |
| 110 | Micronodular cirrhosis (HP:0001413) | 1.80432815 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 1.79388506 |
| 112 | Keratoconjunctivitis sicca (HP:0001097) | 1.79183852 |
| 113 | Loss of speech (HP:0002371) | 1.78932343 |
| 114 | Myositis (HP:0100614) | 1.78410286 |
| 115 | Persistence of primary teeth (HP:0006335) | 1.77501836 |
| 116 | Sparse lateral eyebrow (HP:0005338) | 1.77369922 |
| 117 | Abnormal glucose tolerance (HP:0001952) | 1.77087607 |
| 118 | Scanning speech (HP:0002168) | 1.76855411 |
| 119 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.76394670 |
| 120 | Increased IgE level (HP:0003212) | 1.76210276 |
| 121 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76042690 |
| 122 | Aneurysm (HP:0002617) | 1.75955683 |
| 123 | Glucose intolerance (HP:0000833) | 1.75071866 |
| 124 | Thrombocytosis (HP:0001894) | 1.74848953 |
| 125 | Abnormal foot bone ossification (HP:0010675) | 1.73306940 |
| 126 | Chronic diarrhea (HP:0002028) | 1.71795286 |
| 127 | Pili torti (HP:0003777) | 1.71704461 |
| 128 | Visceral angiomatosis (HP:0100761) | 1.70703627 |
| 129 | Dilatation of the ascending aorta (HP:0005111) | 1.70118859 |
| 130 | Cellulitis (HP:0100658) | 1.69805876 |
| 131 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.69073958 |
| 132 | Hemoptysis (HP:0002105) | 1.69039167 |
| 133 | Tubulointerstitial fibrosis (HP:0005576) | 1.68299446 |
| 134 | Hemangiomatosis (HP:0007461) | 1.67097857 |
| 135 | Blue sclerae (HP:0000592) | 1.66816050 |
| 136 | Hand muscle atrophy (HP:0009130) | 1.66683287 |
| 137 | Platyspondyly (HP:0000926) | 1.66338359 |
| 138 | Amaurosis fugax (HP:0100576) | 1.66082966 |
| 139 | Disinhibition (HP:0000734) | 1.64885784 |
| 140 | Encephalitis (HP:0002383) | 1.64561392 |
| 141 | Glomerulosclerosis (HP:0000096) | 1.63993360 |
| 142 | Abnormality of proline metabolism (HP:0010907) | 1.62990161 |
| 143 | Hydroxyprolinuria (HP:0003080) | 1.62990161 |
| 144 | Renal salt wasting (HP:0000127) | 1.62666642 |
| 145 | Increased CSF protein (HP:0002922) | 1.61778090 |
| 146 | Mitral valve prolapse (HP:0001634) | 1.61738867 |
| 147 | Pulmonary infiltrates (HP:0002113) | 1.61634537 |
| 148 | Axonal loss (HP:0003447) | 1.61482386 |
| 149 | Milia (HP:0001056) | 1.60184806 |
| 150 | Polycythemia (HP:0001901) | 1.59794620 |
| 151 | Bronchitis (HP:0012387) | 1.59511580 |
| 152 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.58003791 |
| 153 | Chronic obstructive pulmonary disease (HP:0006510) | 1.57498355 |
| 154 | Obstructive lung disease (HP:0006536) | 1.57498355 |
| 155 | Recurrent skin infections (HP:0001581) | 1.57139129 |
| 156 | Bone pain (HP:0002653) | 1.56656196 |
| 157 | Abnormality of the acetabulum (HP:0003170) | 1.56409018 |
| 158 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.55039440 |
| 159 | Gingival bleeding (HP:0000225) | 1.54701567 |
| 160 | Beaking of vertebral bodies (HP:0004568) | 1.52804346 |
| 161 | Wormian bones (HP:0002645) | 1.51295463 |
| 162 | Disproportionate tall stature (HP:0001519) | 1.50949304 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.94548821 |
| 2 | RIPK4 | 3.59507974 |
| 3 | PRPF4B | 2.94770876 |
| 4 | MST1R | 2.51351108 |
| 5 | EPHB1 | 2.50831210 |
| 6 | MST4 | 2.49124056 |
| 7 | STK10 | 2.41178841 |
| 8 | TGFBR2 | 2.21382258 |
| 9 | PAK4 | 2.20517021 |
| 10 | FRK | 2.17923347 |
| 11 | KDR | 2.11230731 |
| 12 | LRRK2 | 2.11179538 |
| 13 | LATS1 | 2.05803062 |
| 14 | ERN1 | 1.99141646 |
| 15 | FES | 1.95300492 |
| 16 | PTK6 | 1.88043797 |
| 17 | BMPR2 | 1.84261039 |
| 18 | BTK | 1.83126631 |
| 19 | MAP2K3 | 1.79197451 |
| 20 | SCYL2 | 1.76533048 |
| 21 | SMG1 | 1.75287639 |
| 22 | MET | 1.69897620 |
| 23 | RIPK1 | 1.69011079 |
| 24 | TYK2 | 1.61755019 |
| 25 | TBK1 | 1.57668138 |
| 26 | MAP3K3 | 1.55597929 |
| 27 | YES1 | 1.54181364 |
| 28 | PKN2 | 1.53755763 |
| 29 | MAP4K1 | 1.45225522 |
| 30 | TIE1 | 1.41570204 |
| 31 | TTN | 1.37752867 |
| 32 | ZAP70 | 1.35954119 |
| 33 | CDK12 | 1.35618868 |
| 34 | STK3 | 1.35280520 |
| 35 | EPHA3 | 1.26364529 |
| 36 | TRIB3 | 1.25994442 |
| 37 | SIK1 | 1.21052159 |
| 38 | DDR2 | 1.20693496 |
| 39 | PIM2 | 1.20300305 |
| 40 | MAP3K8 | 1.18834750 |
| 41 | GRK6 | 1.18573529 |
| 42 | SYK | 1.17726717 |
| 43 | BMX | 1.14167506 |
| 44 | CDK6 | 1.11439773 |
| 45 | CSK | 1.10609582 |
| 46 | NEK9 | 1.08981747 |
| 47 | PTK2 | 1.08362900 |
| 48 | MAP3K6 | 1.07575880 |
| 49 | PIK3CG | 1.07080968 |
| 50 | TRPM7 | 1.06800009 |
| 51 | NME2 | 1.06504788 |
| 52 | TESK1 | 1.05448736 |
| 53 | PRKG2 | 1.05260754 |
| 54 | JAK1 | 1.04740570 |
| 55 | BLK | 1.03781980 |
| 56 | KIT | 1.03487890 |
| 57 | MAP3K14 | 1.02071228 |
| 58 | MAP2K2 | 1.00741302 |
| 59 | MAP3K1 | 1.00558297 |
| 60 | TESK2 | 1.00342661 |
| 61 | RPS6KA4 | 1.00328012 |
| 62 | PIM1 | 0.95977124 |
| 63 | JAK3 | 0.94291221 |
| 64 | WNK1 | 0.91754954 |
| 65 | FGFR4 | 0.91335325 |
| 66 | RET | 0.90219725 |
| 67 | FGFR3 | 0.89801883 |
| 68 | TGFBR1 | 0.89146407 |
| 69 | MAP3K11 | 0.88059210 |
| 70 | NLK | 0.86587744 |
| 71 | LYN | 0.86073557 |
| 72 | BRD4 | 0.85474320 |
| 73 | STK39 | 0.81967500 |
| 74 | FLT3 | 0.81885228 |
| 75 | MARK2 | 0.81539989 |
| 76 | PDGFRA | 0.81259970 |
| 77 | EPHB2 | 0.80965909 |
| 78 | ICK | 0.80535873 |
| 79 | GSK3A | 0.79777640 |
| 80 | NEK6 | 0.78890368 |
| 81 | MAP3K2 | 0.78097419 |
| 82 | PDGFRB | 0.77812846 |
| 83 | MARK3 | 0.75659750 |
| 84 | KSR2 | 0.74558927 |
| 85 | RPS6KB2 | 0.74465347 |
| 86 | NUAK1 | 0.74414330 |
| 87 | PDK1 | 0.71849049 |
| 88 | TAOK3 | 0.70712630 |
| 89 | SGK3 | 0.67814468 |
| 90 | CSF1R | 0.67719401 |
| 91 | PDPK1 | 0.67645907 |
| 92 | CAMK1G | 0.66977187 |
| 93 | IKBKB | 0.65501409 |
| 94 | FER | 0.65383259 |
| 95 | MAP3K12 | 0.63649320 |
| 96 | MATK | 0.63478708 |
| 97 | IKBKE | 0.63282743 |
| 98 | ITK | 0.62155902 |
| 99 | PTK2B | 0.61240655 |
| 100 | EGFR | 0.61098023 |
| 101 | TNK2 | 0.60503292 |
| 102 | JAK2 | 0.60484764 |
| 103 | LIMK1 | 0.59753690 |
| 104 | IRAK1 | 0.59043182 |
| 105 | CLK1 | 0.58308765 |
| 106 | MAPKAPK3 | 0.57719869 |
| 107 | MAP3K10 | 0.56801096 |
| 108 | OXSR1 | 0.56481647 |
| 109 | EIF2AK1 | 0.56221358 |
| 110 | MELK | 0.56191730 |
| 111 | CAMK1D | 0.55273372 |
| 112 | PAK2 | 0.54699650 |
| 113 | PRKD2 | 0.54448321 |
| 114 | IRAK4 | 0.54322220 |
| 115 | CHUK | 0.54068120 |
| 116 | WNK4 | 0.54016823 |
| 117 | STK4 | 0.53682376 |
| 118 | ALK | 0.53061697 |
| 119 | TAOK1 | 0.52585884 |
| 120 | NEK2 | 0.52389574 |
| 121 | HCK | 0.52308046 |
| 122 | HIPK2 | 0.52216690 |
| 123 | FYN | 0.51949269 |
| 124 | EEF2K | 0.51665417 |
| 125 | STK24 | 0.48226357 |
| 126 | MAP2K1 | 0.47705887 |
| 127 | MAP3K5 | 0.47665223 |
| 128 | AKT3 | 0.46352411 |
| 129 | CDC42BPA | 0.45866260 |
| 130 | ABL1 | 0.45583881 |
| 131 | IRAK3 | 0.44854009 |
| 132 | LCK | 0.44773567 |
| 133 | TEC | 0.44424064 |
| 134 | STK38 | 0.44062932 |
| 135 | MAP3K13 | 0.43848391 |
| 136 | FGFR2 | 0.42865778 |
| 137 | MTOR | 0.42556968 |
| 138 | ERBB4 | 0.42226038 |
| 139 | PIK3CA | 0.42100989 |
| 140 | FGR | 0.41105214 |
| 141 | MAPKAPK2 | 0.38881849 |
| 142 | SGK2 | 0.38201964 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.06605704 |
| 2 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 2.03603384 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 1.89268741 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.87123581 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 1.86283671 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.83947651 |
| 7 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.83418042 |
| 8 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.82547484 |
| 9 | Shigellosis_Homo sapiens_hsa05131 | 1.82272314 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 1.80681478 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.76584468 |
| 12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.74452763 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72365453 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68487237 |
| 15 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.67602976 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64365906 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.62683987 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58878660 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.56889849 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54605555 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50666829 |
| 22 | Focal adhesion_Homo sapiens_hsa04510 | 1.42213593 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.40914073 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.39747122 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35492343 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34919078 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.32972481 |
| 28 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32592485 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.29882214 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.29501204 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28272990 |
| 32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.26070940 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.26021530 |
| 34 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.25750344 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23776092 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.21591901 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21407697 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18927951 |
| 39 | Phagosome_Homo sapiens_hsa04145 | 1.18755864 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.16135039 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.15324666 |
| 42 | Amoebiasis_Homo sapiens_hsa05146 | 1.14814352 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14326517 |
| 44 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.13568138 |
| 45 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.13031239 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.11622432 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.09004736 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08933344 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08050850 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07550136 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.07483589 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.06841570 |
| 53 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06318034 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 1.05787420 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.05423250 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03478796 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02651900 |
| 58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.00943507 |
| 59 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.99839112 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98254114 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97885837 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.96927490 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96837047 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.95603611 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93880633 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93434473 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.91620702 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91323343 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91257664 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91203988 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.90423540 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89910620 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88485122 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88406525 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84486136 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83344380 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82853732 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81611281 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81398242 |
| 80 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80856913 |
| 81 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.79738457 |
| 82 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79612453 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79233217 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78554850 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.78520478 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78402854 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77512483 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77308319 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.76543687 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.76270224 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73306262 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73260679 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70345477 |
| 94 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69535748 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69035444 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.68997438 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68699861 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.68026553 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67454350 |
| 100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66527397 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64710873 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62963199 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62061234 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61980362 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61837867 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61199972 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58261769 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57606950 |
| 109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57356164 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56658176 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54805324 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54315632 |
| 113 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.54181610 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53632957 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52974706 |
| 116 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52742000 |
| 117 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52172125 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51343093 |
| 119 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49847369 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47331732 |
| 121 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.46347970 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46239358 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45902214 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45109622 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43775976 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43126432 |

